Summary: New research from RCSI University of Medicine and Health Sciences shows that the body’s circadian clock regulates macrophage activity and, in turn, the intensity of inflammation over a 24-hour cycle. Activation of the NLRP3 inflammasome—a central driver of innate immune responses—peaks during the morning when macrophages exhibit higher metabolic and functional readiness. This rhythm is linked to mitochondrial activity and helps explain why inflammatory conditions such as arthritis often flare in the early hours. The findings point to the potential for time-targeted therapies that align treatment with the immune system’s natural daily cycle.
By clarifying when macrophages are most prone to activate inflammasomes, the study suggests that timing anti-inflammatory interventions to periods of peak immune responsiveness could improve outcomes for diseases driven by excessive inflammasome activity. Understanding this immune clock offers a pathway to more precise and effective management of inflammatory disorders.
Key Facts:
- Daily Immune Rhythms: The body’s circadian clock controls macrophage inflammasome activation, which rises to a peak in the morning.
- Mitochondrial Role: Daily changes in mitochondrial function, including membrane potential, underlie time-dependent variations in immune responsiveness.
- Therapeutic Potential: Aligning treatments with immune activity cycles—chronotherapy—could enhance management of inflammasome-driven inflammatory diseases.
Source: RCSI
Overview of the study
Researchers investigated how the internal circadian clock affects macrophage-driven inflammation. Macrophages, key innate immune cells that detect damage and pathogens, assemble multiprotein complexes called inflammasomes to initiate inflammatory responses. The team focused on the NLRP3 inflammasome, a major regulator of IL-1–family cytokine release and pyroptosis, and uncovered a clear time-of-day dependence in its activation.
The study describes inflammasomes as cellular “smoke detectors” that sense danger and sound the alarm to recruit further immune responses. Importantly, activation of NLRP3 is not uniform across the day. Instead, the circadian clock times when macrophages are most efficient at sensing threats and when their energy state allows a robust inflammasome response.
Central to these daily shifts is mitochondrial function. The researchers observed higher mitochondrial membrane potential (Δψm) and greater NLRP3 activation in cells collected at circadian time CT12 compared with CT0. In laboratory-synchronized bone-marrow derived macrophages, inflammasome responses varied according to the time-of-day schedule applied in vitro. Disruption of mitochondrial membrane potential reduced inflammasome activation to similar levels regardless of timing, indicating mitochondria are a mechanistic link between the circadian clock and inflammasome control.
Genetic experiments further implicated the circadian gene Bmal1: myeloid-specific deletion of Bmal1 enhanced NLRP3 activity at times when it would normally be lower. Together, these results show that the macrophage-intrinsic clock, acting through mitochondrial regulation and Bmal1-dependent pathways, gates NLRP3 inflammasome activation across the day.
“When macrophages ‘think’ it’s morning, their inflammasome activation is quicker and more robust,” explained Professor Annie Curtis, the study’s principal investigator at RCSI School of Pharmacy and Biomolecular Sciences. “This evolutionarily sensible timing means the immune response is heightened during the early part of the day, when we are active and more likely to encounter environmental challenges.”
Lead author Dr James O’Siorain noted the translational implications: timing therapies to coincide with peak macrophage activity may improve the effectiveness of new drugs that target inflammasomes, and could help explain daily symptom patterns seen in conditions such as rheumatoid arthritis.
Funding: The research received support from Taighde Éireann – Research Ireland.
About this circadian rhythm and inflammation research news
Author: Laura Anderson
Source: RCSI
Contact: Laura Anderson – RCSI
Image: Image credit: Neuroscience News
Original Research: Open access.
“Time of day control of mitochondria regulates NLRP3 inflammasome activation in macrophages” by Annie Curtis et al., published in FASEB Journal. DOI: 10.1096/fj.202400508RR
Abstract (concise summary)
Macrophages orchestrate inflammation in a time-of-day–dependent manner, aligning immune responses with environmental cycles. The NLRP3 inflammasome mediates release of IL-1 family cytokines through pyroptosis, and mitochondrial function is a critical regulator of NLRP3 activity. Mitochondrial metabolism and membrane potential vary across the day under control of clock genes. This study shows increased mitochondrial membrane potential and enhanced NLRP3 activation at circadian time CT12 versus CT0 in peritoneal exudate cells. In vitro synchronization of bone-marrow derived macrophages produced time-dependent inflammasome responses. Myeloid-specific deletion of Bmal1 enhanced NLRP3 activity at times when it is typically lower, and pharmacological disruption of mitochondrial membrane potential reduced inflammasome activation across time points. These findings demonstrate that circadian control of mitochondrial function, driven in part by Bmal1, times NLRP3 inflammasome activation in macrophages.